The cadherin-catenin adhesion system in signaling and cancer

Journal of Clinical Investigation

Volumn 109, Issue 8, 2002, Pages 987-991

  Conacci Sorrell, Maralice ^a   Zhurinsky, Jacob ^a   Ben Ze'ev, Avri ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CADHERIN; CATENIN; NERVE CELL ADHESION MOLECULE; UVOMORULIN;

CANCER; CANCER GROWTH; CANCER INVASION; CELL ADHESION; CELL GROWTH; CELL MOTILITY; CELL PROLIFERATION; DNA METHYLATION; DOWN REGULATION; GENE REPRESSION; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

EID: 0036120562     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI0215429     Document Type: Review

References (56)

1. Differential molecular interactions of β-catenin and plakoglobin in adhesion, signaling and cancer
2. Molecular architecture of adherens junctions
3. A causal role for E-cadherin in the transition from adenoma to carcinoma
4. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role
5. Inactivation of the E-cadherin-mediated cell adhesion system in human cancers
6. Cancer-epigenetics comes of age
7. Methylation patterns of the E-cadhedn 5′ CpG island are unstable and reflect the dynamic, heterogeneous loss of E-cadherin expression during metastatic progression
8. Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer
9. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression
10. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells
11. The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion
12. A new role for E12/E47 in the repression of E-cadherin expression and epithelial-mesenchymal transitions
13. Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of β-catenin signaling
14. Identification of a neural α-catenin as a key regulator of cadherin function and multicellular organization
15. Expression of wild-type α-catenin protein in cells with a mutant α-catenin gene restores both growth regulation and tumor suppressor activities
16. Hyperproliferation and defects in epithelial polarity upon conditional ablation of α-catenin in skin
17. Linking colorectal cancer to Writ signaling
18. Writ signaling and cancer
19. Overexpression ofcadherins and underexpression of β-catenin inhibit dorsal mesoderm induction in early Xenopus embryos
20. Binding to cadherins antagonizes the signaling activity of β-catenin during axis formation in Xenopus
21. Inhibition of β-carenin-mediared transactivation by cadherin derivatives
22. Differential nuclear translocation and transactivation potential of β-catenin and plakoglobin
23. The cyclin D1 gene is a target of the β-catenin/LEF-1 pathway
24. β-catenin regulates expression of cyclin D1 in colon carcinoma cells
25. Identification ofc-MYC as a target of the APC pathway
26. E-cadherin suppresses cellular transformation by inhibiting β-catenin signaling in an adhesion independent manner
27. E-cadherin regulates cell growth by modulating proliferation-dependent 13-P-catenin transcriptional activity
28. Excess β-catenin promotes accumulation of transcriptionally active p53
29. Deregulated β-catenin induces a p53- and ARF-dependent growth arrest and cooperates with Ras in transformation
30. Down-regulation of β-catenin by activated p53
31. Siah-1 mediates a novel β-catenin degradation pathway linking p53 to the adenomatous polyposis coli protein
32. Siah-1, SIP, and Ebi collaborate in a novel pathway for β-catenin degradation linked to p53 responses
33. The Wnt/Wg signal transducer β-catenin controls fibronectin expression
34. The metalloproteinase matrilysin is a target of β-catenin transactivation in intestinal tumors
35. Transactivation of the multidrug resistance 1 gene by T-cell factor 4/β-catenin complex in early colorectal carcinogenesis
36. Variable β-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment
37. Regulation of β-catenin structure and activity by tyrosine phosphorylation
38. Mutant E-cadherin breast cancer cells do not display constitutive Wnt signaling
39. Leaving the neighborhood: Molecular mechanisms involved during epithelial-mesenchymal transition
40. An overview of epithelio-mesenchymal transformation
41. Tyrosine phosphorylation regulates the adhesions of ras-transformed breast epithelia
42. Regulation of E-cadherin/catenin association by tyrosine phosphorylagon
43. Activation of both MAP kinase and phosphatidylinositide 3-kinase by Ras is required for hepatocyte growth factor/scatter factor-induced adherens junction disassembly
44. Casein kinase II phosphorylation of E-cadherin increases E- cadherin/β-catenin interaction and strengthens cell-cell adhesion
45. Cadherin sequences that inhibit β-catenin signaling: A study in yeast and mammalian cells
46. Density-dependent inhibition of growth involves prevention of EGF receptor activation by E-cadherin-mediated cell-cell adhesion
47. E-cadherin-dependent growth suppression is mediated by the cyclin dependent kinase inhibitor p27(KIP1)
48. N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression
49. Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis
50. Rho family proteins: Coordinating cell responses
51. Rho GTPases and signaling networks
52. The small GTPases Rho and Rac are required for the establishment of cadherin-dependent cell-cell contacts
53. Regulation of cell-cell adhesion by rac and rho small G proteins in MDCK cells
54. Inhibition of invasion of epithelial cells by Tiam 1-Rac signaling
55. Rho-family GTPases in cadherin-mediated cell-cell adhesion
56. Plakoglobin and β-catenin: Protein interactions, regulation and biological roles